Pick of The Week 22062024

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

Buy

Pick of the Week JK Lakshmi Cement Ltd Target Price

22nd June, 2024 Cement 915

About the Company

Duration: 6-9 Months JK Lakshmi Cement (JKLC) is a dominant player in the cement industry, particularly in its key markets of North and West India,
from which it derives 75% of its revenue. The company also has a significant market presence in Eastern India. On a
consolidated basis, JKLC's total cement capacity stands at over 16 million tonnes per annum (mtpa).
Potential
CMP Target
Upside Investment Rationale
(Rs) (Rs)
(%)
A. Capacity expansion to drive higher revenue growth: The setting up of a grinding unit in Surat with a capacity of 1.35 mtpa at a
830 915 10% capital cost of Rs 220 Cr, funded through a mix of internal accruals and debt, is progressing well. The facility is expected to
commence operations in phases between FY25 and FY26. Additionally, the company's capacity expansion plan of 4.6 mtpa Cement
Grinding and 2.3 mtpa Clinker, at a capital cost of Rs 2,500 Cr (USD 65/tonne), will be commissioned in phases over FY26-27. These
MARKET DATA
expansions are anticipated to boost JK Lakshmi Cement's market share and revenue growth moving forward. We expect the
company to grow its revenue at a CAGR of 9% over FY24-26E.
No. of Shares 11.8 Cr
B. Higher EBITDA/tonne: During Q4FY24, the company reported an EBITDA/tonne of Rs 1,080, the highest in recent times, due to
Market Cap 9794 Cr various initiatives undertaken. The company expects to build on these initiatives, which include optimizing geo-mix, achieving higher
production and sale of blended cement, increasing the proportion of trade sales, premium and value-added products, enhancing
logistic efficiency, and utilizing more renewable power. We anticipate the company to grow EBITDA/tonne at a CAGR of 18% over
52-week High / Low 1000/607
FY23-26E, reaching Rs 1,100/tonne. This growth will be driven by stable realization, higher volume, and cost-saving initiatives.

BSE Code 500380 C. Cement demand to sustain: Cement demand in the country is expected to remain robust, driven by higher capital spending by the
central government on roads, railways, and housing, as well as strong real estate demand. Increasing investment in developing the
country's infrastructure will act as a catalyst for higher cement demand. The industry is expected to grow at a CAGR of 8-9% during
NSE Code JKLAKSHMI
FY23-FY26E.
D. Outlook & Valuation: The company’s topline and margins are expected to enhance on account of its superior positioning in the key
Why JK Lakshmi Cement Ltd markets of North, West, and East India along with its various initiatives such as its focus on increasing sales of premium and value-
added products, higher blending ratio and trade sales, more use of green energy and direct dispatches. We expect JKLC to report
 Capacity expansion to drive Revenue/EBITDA/APAT CAGR of 9%/22%/23% respectively over FY23-FY26E. The stock is currently trading at 10x and 8x
FY25E/FY26E EV/EBITDA, which we believe is attractive.
revenue growth.
E. Recommendation: We recommend a BUY the stock for a target price of Rs 915/ implying an upside of 10% from CMP
 Cost optimization to drive EBITDA
Financial Summary (Standalone)
margin.
Y/E Net Sales EBITDA Net Profit EPS PER EV/EBIDTA P/BV RoE
 Robust Cement demand March (Rs Cr) (Rs Cr) (Rs Cr) (Rs) (x) (x) (x) (%)
 Attractive valuation FY24 6,320 864 433 37 23 12 3.0 15
FY25E 6,695 1,048 532 45 29 10 2.8 16
FY26E 7,487 1,291 658 56 15 8 2.4 17
Source: Axis Securities. CMP as on 21st June, 2024
Disclosures:

The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).

1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services,
Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and has its various
subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com.

2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and
also registered with IRDA as a corporate agent for insurance business activity.

3. ASL has no material adverse disciplinary history as on the date of publication of this report.

4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We (Research
Analyst) also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL or its Associate does not have any
financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of
publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject
company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director / officer, employee etc. in the subject company in the last
12-month period.
Sr.
Name Designation E-mail
No
1 Neeraj Chadawar Head of Research [email protected]
2 Preeyam Tolia Research Analyst [email protected]
3 Omkar Tanksale Research Analyst [email protected]
4 Uttamkumar Srimal Research Analyst [email protected]
5 Ankush Mahajan Research Analyst [email protected]
6 Dnyanada Vaidya Research Analyst [email protected]
7 Aditya Welekar Research Analyst [email protected]
8 Sani Vishe Research Analyst [email protected]
9 Akshay Mokashe Research Analyst [email protected]
10 Eesha Shah Research Analyst [email protected]
11 Shridhar Kallani Research Associate [email protected]
12 Shikha Doshi Research Associate [email protected]
13 Pranav Nawale Research Associate [email protected]
14 Suhanee Shome Research Associate [email protected]
15 Shivani More Research Associate [email protected]
16 Darsh Solanki Research Associate [email protected]

5. ASL or its Associates has not received any compensation from the subject company in the past twelve months. I/We or ASL or its Associate has not been engaged in market making activity for the subject company.

6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have:
i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or;
ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or;
iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report;

ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report.

Terms & Conditions:


This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or
distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and
accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no
guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational
purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers
may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report.
NEERAJ Digitally signed by NEERAJ
CHADAWAR

CHADAWAR Date: 2024.06.21 16:36:02


+05'30'

Disclaimer:
Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient’s specific circumstances. The
securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment
objectives, financial positions and needs of specific recipient.
This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an
independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and
risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for
all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on
basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past
performance is not necessarily a guide to future performance. Investors are advice necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the
risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to
change without notice.
ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be
engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an
advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. The Research reports are also available
& published on AxisDirect website.
ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may
have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service
transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed
or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention
of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such
distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described
herein may or may not be eligible for sale in all jurisdictions or to certain category of investors.
The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The
Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the
Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited.

Copyright in this document vests with Axis Securities Limited.


Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI – INZ000161633, ARN No. 64610, CDSL-IN-DP-CDSL-693-2013, SEBI-Research Analyst Reg. No. INH 000000297, SEBI Portfolio
Manager Reg. No.- INP000000654, Main/Dealing off.- Axis Securities Ltd, Unit No.1001, 10th Floor, Level-6, Q2 Building, Aurum, Q Parc, Plot No. 4/1, TTC, Thane – Belapur Road, Ghansoli, Navi
Mumbai. – 400 710., Regd. off.- Axis House,8th Floor, Wadia International Centre, PandurangBudhkar Marg, Worli, Mumbai – 400 025.
Compliance Officer: Jatin Sanghani, Email: [email protected], Tel No: 022-49212706

You might also like